$5.1M Awarded to the TemPredict Study Directed by Ashley Mason, PhD
Misguided Use of Hydroxychloroquine for COVID-19: The Infusion of Politics Into Science | Critical Care Medicine | JAMA | JAMA Network
10/11/2020
Le ministère de la Santé met à disposition les données d’utilisation de l’application TousAntiCovid
10/11/2020
UCSF Osher Center faculty member Ashley Mason, PhD, has received a $5.1M award to expand TemPredict, a study she directs in collaboration with Rick Hecht, MD, and Benjamin Smarr, PhD.
Lire l’article complet sur : osher.ucsf.edu
